The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Serous Cystadenoma of the Pancreas: Tumor Growth Rates and Recommendations for Treatment
Open accessAbstract
OBJECTIVE: To define the natural history and optimal management of serous cystadenoma of the pancreas. SUMMARY BACKGROUND DATA: Serous cystadenoma of the pancreas is the most common benign pancreatic neoplasm. Diagnostic criteria, potential for growth or malignancy, and outcomes are not well defined. As a result, management for patients with serous cystadenomas varies widely in current practice. METHODS: A total of 106 patients presenting with serous cystadenoma of the pancreas from 1976-2004 were identified. Hospital records were evaluated for patient and tumor characteristics, diagnostic workup, treatment, and outcome. Twenty-four patients with serial radiographic imaging were identified, and tumor growth curves calculated. RESULTS: Mean age at presentation was 61.5 years and 75% of patients were female. The most common symptoms were abdominal pain (25%), fullness/mass (10%), and jaundice (7%); 47% were asymptomatic. Mean tumor diameter was 4.9 +/- 3.1 cm, which did not vary by location. Tumors <4 cm were less likely to be symptomatic than were tumors > or =4 cm (22% vs. 72%, P < 0.001). The median growth rate in the patients who had serial radiography was 0.60 cm/y. For tumors <4 cm at presentation (n = 15), the rate was 0.12 cm/y, whereas for tumors > or =4 cm (n = 9), the rate was 1.98 cm/y (P = 0.0002). Overall, 86 patients underwent surgery, with one perioperative death. CONCLUSIONS: Large (>4 cm) serous cystadenomas are more likely to be symptomatic. Although the median growth rate for this neoplasm is only 0.6 cm/y, it is significantly greater in large tumors. Whereas expectant management is reasonable in small asymptomatic tumors, we recommend resection for large serous cystadenomas regardless of the presence or absence of symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Determination of subcutaneous tumor size in athymic (nude) mice
Tomayko, M. M., & Reynolds, C. P. (1989) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00300234 · Cited by 1,830
Cystic Neoplasms of the Pancreas
Brugge, W. R., Lauwers, G. Y., Sahani, D., Fernandez-del Castillo, C., & Warshaw, A. L. (2004) · New England Journal of Medicine · doi:10.1056/nejmra031623 · Cited by 805
Self-citationObservations on growth rates of human tumors.
Collins, V. P., Loeffler, R. K., & Tivey, H. (1956) · PubMed · Cited by 758
Compagno, J., & Oertel, J. E. (1978) · American Journal of Clinical Pathology · doi:10.1093/ajcp/69.6.573 · Cited by 696
WARSHAW, A. L., COMPTON, C. C., LEWANDROWSKI, K., CARDENOSA, G., & MUELLER, P. R. (1990) · Annals of Surgery · doi:10.1097/00000658-199010000-00006 · Cited by 639
Self-citationCastillo, C. F.-D. (2003) · Archives of Surgery · doi:10.1001/archsurg.138.4.427 · Cited by 618
Self-citationA biomathematical approach to clinical tumor growth
Schwartz, M. (1961) · Cancer · doi:10.1002/1097-0142(196111/12)14:6<1272::aid-cncr2820140618>3.0.co;2-h · Cited by 548
Compagno, J., & Oertel, J. E. (1978) · American Journal of Clinical Pathology · doi:10.1093/ajcp/69.1.289 · Cited by 530
Le Borgne, J., de Calan, L., & Partensky, C. (1999) · Annals of Surgery · doi:10.1097/00000658-199908000-00004 · Cited by 480
Estimation of liver tumor volume using different formulas?An experimental study in rats
Carlsson, G., Gullberg, B., & Hafstr�m, L. (1983) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf00391826 · Cited by 301
Cited by
European evidence-based guidelines on pancreatic cystic neoplasms
The European Study Group on Cystic Tumours of the Pancreas (2018) · Gut · doi:10.1136/gutjnl-2018-316027 · Cited by 1,417
Managing Incidental Findings on Abdominal CT: White Paper of the ACR Incidental Findings Committee
Berland, L. L., Silverman, S. G., Gore, R. M., Mayo-Smith, W. W., Megibow, A. J., Yee, J., Brink, J. A., Baker, M. E., Federle, M. P., Foley, W. D., et al. (2010) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2010.06.013 · Cited by 868
Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development
Wu, J., Matthaei, H., Maitra, A., Dal Molin, M., Wood, L. D., Eshleman, J. R., Goggins, M., Canto, M. I., Schulick, R. D., Edil, B. H., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002543 · Cited by 782
European experts consensus statement on cystic tumours of the pancreas
Del Chiaro, M., Verbeke, C., Salvia, R., Klöppel, G., Werner, J., McKay, C., Friess, H., Manfredi, R., Van Cutsem, E., Löhr, M., et al. (2013) · Digestive and Liver Disease · doi:10.1016/j.dld.2013.01.010 · Cited by 498
Jais, B., Rebours, V, Malleo, G., Salvia, R., Fontana, M., Maggino, L., Bassi, C., Manfredi, R., Moran, R., Lennon, A. M., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-309638 · Cited by 372
Metadata
- Authors
- Tseng, J. F., Warshaw, A. L., Sahani, D. V., Lauwers, G. Y., Rattner, D. W., & Castillo, C. F.-D.
- Venue
- Annals of Surgery
- Published
- 2005-09
- Volume
- 242
- Issue
- 3
- Pages
- 413-421
- ISSN
- 0003-4932 (ISSN-L)
- OpenAlex
- W2024008214
- Cited by
- 400
- References
- 26
- FWCI
- 8.62
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serous Cystadenoma of the Pancreas: Tumor Growth Rates and Recommendations for Treatment. https://app.cochat.ai/papers/10.1097/01.sla.0000179651.21193.2c
- The paper
- Tseng, J. F., Warshaw, A. L., Sahani, D. V., Lauwers, G. Y., Rattner, D. W., & Castillo, C. F.-D. (2005). Serous Cystadenoma of the Pancreas: Tumor Growth Rates and Recommendations for Treatment. Annals of Surgery. https://doi.org/10.1097/01.sla.0000179651.21193.2c
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.